Aperio Group’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $611K | Sell |
7,929
-140
| -2% | -$10.8K | ﹤0.01% | 1862 |
|
|
2020
Q3 | $594K | Buy |
8,069
+301
| +4% | +$22.2K | ﹤0.01% | 1721 |
|
|
2020
Q2 | $570K | Sell |
7,768
-217
| -3% | -$15.9K | ﹤0.01% | 1715 |
|
|
2020
Q1 | $461K | Sell |
7,985
-2,006
| -20% | -$116K | ﹤0.01% | 1693 |
|
|
2019
Q4 | $785K | Buy |
9,991
+203
| +2% | +$16K | ﹤0.01% | 1569 |
|
|
2019
Q3 | $669K | Sell |
9,788
-6,461
| -40% | -$442K | ﹤0.01% | 1602 |
|
|
2019
Q2 | $1.29M | Sell |
16,249
-4,543
| -22% | -$361K | 0.01% | 1260 |
|
|
2019
Q1 | $1.74M | Sell |
20,792
-2,361
| -10% | -$198K | 0.01% | 1089 |
|
|
2018
Q4 | $2.73M | Sell |
23,153
-3,868
| -14% | -$455K | 0.01% | 866 |
|
|
2018
Q3 | $3.26M | Sell |
27,021
-1,336
| -5% | -$161K | 0.01% | 830 |
|
|
2018
Q2 | $3.27M | Buy |
28,357
+3,028
| +12% | +$349K | 0.02% | 813 |
|
|
2018
Q1 | $2.18M | Buy |
25,329
+2,780
| +12% | +$239K | 0.01% | 961 |
|
|
2017
Q4 | $1.67M | Buy |
22,549
+9,411
| +72% | +$697K | 0.01% | 1059 |
|
|
2017
Q3 | $758K | Buy |
13,138
+1,653
| +14% | +$95.4K | ﹤0.01% | 1437 |
|
|
2017
Q2 | $736K | Buy |
11,485
+1,149
| +11% | +$73.6K | ﹤0.01% | 1407 |
|
|
2017
Q1 | $595K | Buy |
10,336
+5,644
| +120% | +$325K | ﹤0.01% | 1441 |
|
|
2016
Q4 | $287K | Buy |
4,692
+278
| +6% | +$17K | ﹤0.01% | 1817 |
|
|
2016
Q3 | $305K | Buy |
4,414
+496
| +13% | +$34.3K | ﹤0.01% | 1700 |
|
|
2016
Q2 | $218K | Buy |
3,918
+442
| +13% | +$24.6K | ﹤0.01% | 1821 |
|
|
2016
Q1 | $211K | Buy |
3,476
+90
| +3% | +$5.46K | ﹤0.01% | 1846 |
|
|
2015
Q4 | $216K | Buy |
3,386
+340
| +11% | +$21.7K | ﹤0.01% | 1788 |
|
|
2015
Q3 | $204K | Buy |
3,046
+6
| +0.2% | +$402 | ﹤0.01% | 1760 |
|
|
2015
Q2 | $208K | Buy |
+3,040
| New | +$208K | ﹤0.01% | 1839 |
|